Skip to main content
. 2016 Feb 16;8(3):168–175. doi: 10.1177/1758834016631529

Figure 1.

Figure 1.

Generation of humoral and cellular immunity with INO-3112 (VGX 3100 plus INO 9112, adjuvant interleukin 12) and electoporation [ClinicalTrials.gov identifier: NCT02163057]. Image courtesy of Dr Mark Bagarazzi, Inovio Pharmaceuticals, Plymouth Meeting, PA, USA.